Anthropic CEO Dario Amodei says public trust in AI is weak and that companies need to prove their claims with real-world outcomes. In remarks reported by multiple outlets, he argues that AI firms have overpromised while failing to deliver at scale, contributing to skepticism.
Amodei emphasizes that credibility will be rebuilt through tangible benefits rather than marketing. A key example he cites is curing cancer or making comparable breakthroughs, framing medical results as a way for AI to demonstrate value to the public. He also comments on the broader debate over AI regulation, saying oversight should exist but that it should not concentrate too much power in any single place.
Across the coverage, the main differences are in emphasis: Business Insider focuses on the public’s distrust and Amodei’s view that AI companies have oversold; Times of India adds that he directs companies not to deflect criticism and highlights Anthropic’s interest in biological and medical progress as a path to demonstrating usefulness.
